BACKGROUND: @entity158 ( @entity158 ) was used as a reference in the literature as @entity6865 related to calcineurin inhibitors. Much of the literature describes @entity158 that occurred after kidney and bone marrow transplantation. We describe a rare case of @entity158 in induction immunosuppression before kidney transplantation, under administration of an anti-rheumatoid drug. METHODS: A 53-year-old @entity1 had pre-status of ABO-incompatible living kidney transplantation. The @entity1 had @entity309 , but that was well-controlled with @entity3378 as an anti-rheumatoid drug. Fourteen days before transplantation, she received induction immunosuppressive therapy consisting of @entity1140 ( @entity5467 ) and @entity618 ( @entity2098 ) and she stopped taking @entity3378 . The third day after that treatment, she had a high @entity158 of the knees, elbows, and wrists. RESULTS: When the @entity1 stopped taking @entity5467 and @entity2098 and started taking @entity3378 again, she soon recovered. Next, we challenged same induction immunosuppression therapy with administration of @entity3378 ; however, the @entity1 had the same symptom. We considered that the symptom was caused by @entity5467 or @entity2098 , and we did not challenge-test each drug. We found that taking only @entity5467 caused the same symptom for the @entity1 . Also, we challenged @entity205 ( @entity9472 ) with @entity2098 and confirmed that she did not have the symptom. CONCLUSIONS: We decided that drugs of the induction immunosuppression therapy were @entity9472 , @entity2098 , @entity617 , and basiliximab. The @entity1 received induction therapy with plasmapheresis and rituximab in addition to the above-mentioned drugs, and we performed ABO-incompatible kidney transplantation for her. The post-surgical course was good, without acute rejection, and she had no @entity158 .

Calcineurin Inhibitor-Induced XXXX Syndrome in ABO-Incompatible Living Kidney Transplantation: A Case Report.

@entity1 :: ('9606', 'Species') :: ['woman', 'patient'] @entity9472 :: ('D016572', 'Chemical') :: ['CsA'] @entity309 :: ('MESH:D001172', 'Disease') :: ['rheumatoid arthritis'] @entity6865 :: ('MESH:D012019', 'Disease') :: ['reflex sympathetic dystrophy syndrome'] @entity205 :: ('MESH:D016572', 'Chemical') :: ['cyclosporine'] @entity5467 :: ('D016559', 'Chemical') :: ['TAC'] @entity2098 :: ('CHEBI:8764', 'Chemical') :: ['MMF'] @entity618 :: ('MESH:C063008', 'Chemical') :: ['mycophenolate mofetil'] @entity158 :: ('MESH:D010146', 'Disease') :: ['pain', 'fever, fatigue, and joint pains', 'CIPS', 'Calcineurin-inhibitor-induced pain syndrome'] @entity1140 :: ('MESH:D016559', 'Chemical') :: ['tacrolimus'] @entity3378 :: ('MESH:D012460', 'Chemical') :: ['salazosulfapyridine'] @entity617 :: ('MESH:D011239', 'Chemical') :: ['prednisolone']
@entity158 :: (MESH:D010146,Disease) :: ['Pain']
